Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and ...

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...

Jim Cramer recently endorsed Pfizer, excited by its cancer-fighting potential and robust drug pipeline. A caller praised ...

Pfizer Vietnam, in collaboration with the Vietnam Association of Preventive Medicine, organised on June 3 and June 5 a series ...

Two drugs. Two strategies. One industry in the middle of a rewiring.

The Sport Impact Summit (SIS) has announced two major strategic partnerships with Scoreboard, sport’s leading AI-powered ...

BIOSeedin Innovation Partnering Conference solidified its role as a nexus for global biopharma innovation, attracting more than 2,000 registrants from 10 countries. Senior executives and investors ...

Under terms of the deal, both companies will co-develop and co-commercialize BNT327 for multiple solid tumors, with the ...

Helgi Kormaksson Joins CTS Executive Team SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / CTS is excited to announce that Helgi Kormaksson has joined the company as Chief Design Officer. Helgi ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...